Ricerca avanzata

Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2012 Ottobre;78(10) > Minerva Anestesiologica 2012 Ottobre;78(10):1146-53

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA ANESTESIOLOGICA

Rivista di Anestesia, Rianimazione, Terapia Antalgica e Terapia Intensiva

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Periodicità: Mensile

ISSN 0375-9393

Online ISSN 1827-1596

 

Minerva Anestesiologica 2012 Ottobre;78(10):1146-53

 EXPERT OPINIONS

Recent advances in interfaces for non-invasive ventilation: from bench studies to practical issues

Sferrazza Papa G. F. 1, 2, Di Marco F. 2, Akoumianaki E. 1, 3, Brochard L. 1, 4

1 Intensive Care Department, University Hospital, Geneva, Switzerland;
2 Clinica di Malattie dell’Apparato Respiratorio, Ospedale San Paolo, Università degli Studi di Milano, Milano, Italia;
3 Department of Intensive Care Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece;
4 University of Geneva, Geneva, Switzerland

The interface is the defining element of non-invasive ventilation (NIV). Nowadays different types of interfaces, which differ in terms of shape, mechanical properties and comfort, are available, and their choice and fitting is a key element of NIV success. In the last decade, larger masks covering the entire face and specifically designed helmets have been developed for delivering NIV, theoretically improving comfort and patient tolerance. Recent studies have shown that, despite marked heterogeneity in mask internal volume and compliance, the dynamic dead space and, above all, the clinical efficacy of different masks is on average very similar. Thus, with the exception of the nasal mask and the mouthpiece, a variety of interfaces for NIV can be used in the acute care setting. However, prevention and monitoring of interfaces related side-effects and evaluation of patient tolerance are crucial to avoid NIV failure. To optimize effectiveness and costs, an interface strategy for NIV in acute respiratory failure could be convenient in clinical practice.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina